1-O-hexadecyl-2-lyso-glycero-3-phosphorylcholine,
lyso-GEPC,
1-O-Hexadecyl-sn-glycero-3-phosphocholine,
1-hexadecyl-sn-glycero-3-phosphocholine,
52691-62-0,
PC(O-16:0/0:0),
CHEBI:64496,
MFCD00042932,
1-O-Palmityl-sn-glycero-3-phosphocholine,
1-O-Hexadecyl-sn-glyceryl-3-phosphorylcholine,
1-O-Hexadecyl-sn-glycero-3-phosphatidylcholine,
1-O-Hexadecyl-2-lyso-sn-glycero-3-phosphocholine,
Lyso-gepc,
(2r)-3-(hexadecyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate,
3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-,
C24H52NO6P,
1-palmityl-GPC,
Lyso-platelet activating factor C16,
Lyso-PAF-C16,
AC1L4QQC,
LYSO-PAF C16,
1-O-Hexadecyl-2-lyso-glycero-3-phosphorylcholine,
Lyso-platelet activating factor,
BML3-E04,
CHEMBL479687,
CTK5H9209,
HMS1791G06,
HMS1989G06,
HMS3402G06,
HMS3648P08,
LPC(O-16:0),
1308AH,
LMGP01060010,
lysophosphatidylcholine O-16:0/0:0,
LPC O-16:0/0:0,
Lysophosphatidylcholine(O-16:0/0:0),
ACM52691620,
GPC(O-16:0/0:0),
NCGC00161374-01,
NCGC00161374-02,
NCGC00161374-03,
3-sn-Lysophosphatidylcholine, 1-hexadecyl,
PC O-16:0/0:0,
(R)-3-(hexadecyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate,
[(2R)-3-hexadecoxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate,
C16 Lyso PAF, 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine, powder,
(2-{[(2R)-3-(hexadecyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium,
C16 Lyso PAF, 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform,
Lyso PAF (from Heart PC), 1-alkyl-2-hydroxy-sn-glycero-3-phosphocholine, powder,
97288-09-0,
lysoPC 16:0,
Lyso-PAF C-16,
lyso-Platelet-activating factor,
C24-H52-N-O6-P,
CID162126,
C13903,